Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 22 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

32%

7 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed trials have results

Key Signals

4 recruiting3 with results

Enrollment Performance

Analytics

N/A

10(55.6%)

Phase 3

5(27.8%)

Phase 4

2(11.1%)

Phase 2

1(5.6%)

18Total

N/A(10)

Phase 3(5)

Phase 4(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (22)

Showing 20 of 22 trials

NCT07784647Completed

A Combination Triple Pill Implementation Strategy for Blood Pressure cONtrol

Role: collaborator

NCT07687056Phase 3Not Yet Recruiting

ACT-GLOBAL IA Thrombolysis(ACT-REACT-004)Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Role: collaborator

NCT05564754Not ApplicableActive Not Recruiting

Sedation, Temperature and Pressure After Cardiac Arrest and Resuscitation

Role: collaborator

NCT06429332Phase 4Recruiting

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Role: collaborator

NCT06320431Phase 3Recruiting

ACT-GLOBAL THROMBOLYSIS (ACT-WHEN-001) Domain Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632

Role: collaborator

NCT06207942Not ApplicableRecruiting

Stepcare Extended Follow-up Substudy

Role: collaborator

NCT03734640Not ApplicableCompleted

Optimal Post Tpa-Iv Monitoring in Ischemic Stroke

Role: collaborator

NCT06003621Phase 2Recruiting

Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients

Role: collaborator

NCT04497376Not ApplicableCompleted

Comparison Between Upgraded '2C3L' vs. PVI Approach for Catheter Ablation of Persistent Atrial Fibrillation

Role: collaborator

NCT03551327Not ApplicableCompleted

POst Stroke Intervention Trial In Fatigue (POSITIF)

Role: collaborator

NCT04567433Completed

Days Alive and Out of Hospital for Patients With Sepsis

Role: lead

NCT04347330Not ApplicableUnknown

Cardiovascular Risk Reduction in Atrial Fibrillation Trial

Role: collaborator

NCT04509973Phase 3Completed

Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia

Role: collaborator

NCT02065791Phase 3Completed

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

Role: collaborator

NCT03005509Not ApplicableCompleted

Structured Trauma Quality Improvement Meetings at Four Trauma Centres in India

Role: collaborator

NCT01989754Phase 4Completed

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus

Role: collaborator

NCT01032629Phase 3Completed

CANVAS - CANagliflozin cardioVascular Assessment Study

Role: collaborator

NCT02877342Unknown

Pre-hospital Notification of Injured Patients Presenting to Trauma Centres in India

Role: collaborator

NCT02002013Completed

The Fluid Translation of Research Into Practice Study

Role: lead

NCT02123875Not ApplicableCompleted

ATTEND-Family-led Rehabilitation After Stroke in India

Role: collaborator